Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
Eduardo Medronha, Interventional Radiologist and Interventional Oncologist at IntervIR at IntervIR, shared a post on LinkedIn:
”DIPS as a rescue strategy in Budd-Chiari syndrome – a challenging case
Sharing a case that highlights a technical alternative worth keeping in mind when hepatic vein access fails in Budd-Chiari syndrome.
Clinical context:
A patient with Budd-Chiari syndrome, previously treated with TIPS and with several years of well-controlled ascites, presented with recurrent symptoms. Stent evaluation confirmed the existing shunt remained patent, and a second, parallel shunt was indicated to optimize portal decompression.
Technical challenge:
Hepatic vein catheterization was not feasible due to thrombosis-a recognized limitation of conventional TIPS in Budd-Chiari syndrome, where the hepatic veins are frequently the primary site of disease.
Approach:
A DIPS (direct intrahepatic portosystemic shunt) was performed as a rescue strategy: a single percutaneous puncture with a Chiba needle traversed both the portal vein and the retrohepatic inferior vena cava directly, the guidewire was captured within the vena cava, and the shunt was created along this direct portal-caval tract-circumventing the thrombosed hepatic veins.
Why this matters:
DIPS is a well-described but underused technique for patients in whom hepatic vein access is anatomically or technically unfeasible-particularly relevant in Budd-Chiari syndrome, where venous occlusion is often the rule rather than the exception.
Having this approach in the technical repertoire can be the difference between completing portal decompression and abandoning the procedure.
Open to hearing how others have approached hepatic vein access failure in Budd-Chiari syndrome–DIPS, transcaval approaches, or other strategies.”

Stay updated with Hemostasis Today.
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory
-
Sep 26, 2026, 07:01David McIntosh: Plasma Derived Medicines and the Global Access Gap
-
Sep 26, 2026, 06:49Heghine Khachatryan: Navigating the Complexities of Pediatric VTE
-
Sep 26, 2026, 06:44Emmanuel J Favaloro: A Century of von Willebrand Disease 2026 Virtual Issue
-
Sep 26, 2026, 05:12Saja Al-Zamili: Dual Antithrombotic Therapy After Ischemic Stroke in Atrial Fibrillation – A Meta-Analysis